JP2021523936A5 - - Google Patents

Info

Publication number
JP2021523936A5
JP2021523936A5 JP2021510529A JP2021510529A JP2021523936A5 JP 2021523936 A5 JP2021523936 A5 JP 2021523936A5 JP 2021510529 A JP2021510529 A JP 2021510529A JP 2021510529 A JP2021510529 A JP 2021510529A JP 2021523936 A5 JP2021523936 A5 JP 2021523936A5
Authority
JP
Japan
Prior art keywords
complex
gold
iii
independently selected
alkyl
Prior art date
Application number
JP2021510529A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021523936A (ja
JP7499755B2 (ja
JPWO2019211222A5 (https=
Filing date
Publication date
Priority claimed from EP18382305.3A external-priority patent/EP3564246B1/en
Application filed filed Critical
Publication of JP2021523936A publication Critical patent/JP2021523936A/ja
Publication of JP2021523936A5 publication Critical patent/JP2021523936A5/ja
Publication of JPWO2019211222A5 publication Critical patent/JPWO2019211222A5/ja
Application granted granted Critical
Publication of JP7499755B2 publication Critical patent/JP7499755B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021510529A 2018-05-03 2019-04-29 金（ｉｉｉ） 錯体、金（ｉｉｉ） 錯体のコンジュゲート、金（ｉｉｉ） 錯体を含む医薬組成物、金（ｉｉｉ） 錯体を生成する方法とその使用。 Active JP7499755B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18382305.3A EP3564246B1 (en) 2018-05-03 2018-05-03 A gold(iii) complex, a conjugate of the gold(iii) complex, a pharmaceutical composition comprising the gold(iii) complex and uses and a process for preparing the gold(iii) complex
EP18382305.3 2018-05-03
PCT/EP2019/060879 WO2019211222A1 (en) 2018-05-03 2019-04-29 A gold(iii) complex, a conjugate of the gold(iii) complex, a pharmaceutical composition comprising the gold(iii) complex and uses and a process for preparing the gold(iii) complex

Publications (4)

Publication Number Publication Date
JP2021523936A JP2021523936A (ja) 2021-09-09
JP2021523936A5 true JP2021523936A5 (https=) 2022-04-05
JPWO2019211222A5 JPWO2019211222A5 (https=) 2022-04-05
JP7499755B2 JP7499755B2 (ja) 2024-06-14

Family

ID=62222548

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021510529A Active JP7499755B2 (ja) 2018-05-03 2019-04-29 金（ｉｉｉ） 錯体、金（ｉｉｉ） 錯体のコンジュゲート、金（ｉｉｉ） 錯体を含む医薬組成物、金（ｉｉｉ） 錯体を生成する方法とその使用。

Country Status (10)

Country Link
US (1) US11866455B2 (https=)
EP (1) EP3564246B1 (https=)
JP (1) JP7499755B2 (https=)
KR (1) KR20210008020A (https=)
CN (1) CN112638922B (https=)
CA (1) CA3098778A1 (https=)
DK (1) DK3564246T3 (https=)
ES (1) ES2893849T3 (https=)
MX (1) MX2020011557A (https=)
WO (1) WO2019211222A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022072545A1 (en) * 2020-09-29 2022-04-07 University Of Kentucky Research Foundation Multi-coordinate gold-phosphine compounds and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9709471A (es) * 1995-06-07 1998-02-28 Univ Washington Complejos metalicos multidentados y metodos para preparar y usar los mismos.
GB0900961D0 (en) * 2009-01-20 2009-03-04 Univ Bath Antimicrobial coating
WO2013091014A1 (en) * 2011-12-22 2013-06-27 James Cook University Antimicrobial agents

Similar Documents

Publication Publication Date Title
MX2025000642A (es) Compuestos macrociclicos para el tratamiento de cancer
HUP0303756A2 (hu) 1-Aril- vagy 1-alkilszulfonil-heterociklobenzazolok és eljárás ezek elõállítására és ezeket tartalmazó gyógyszerkészítmények
HUP0401009A2 (hu) 5-Hidroxitriptamin-6-ligandumokként alkalmazható 1-aril- vagy 1- alkil-szulfonilbenzazol-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
JP2014503574A5 (https=)
ATE419245T1 (de) Cinnoline verbindungen
MX2008010187A (es) Tratamiento de distrofia muscular de duchenne.
WO2008115098A3 (fr) 2,3,4,5-tétrahydro-1h-pyrido[4,3-b]indoles substitués ainsi que procédés de leur fabrication et leur utilisation
MXPA01004256A (es) N-arilamidas del acido antranilico y del acido tioantranilico.
NO20075169L (no) Nye imidazo (1,5-A)pyndindenvater, fremgangsmate for fremstilling og farmasoytiske sammensetninger som inneholder samme.
HUP0103511A2 (hu) Oxazolszármazékok, valamint ezeket tartalmazó gyógyászati készítmények és eljárás a vegyületek előállítására
CN107188898B (zh) 制备噻吩并嘧啶化合物的方法
TW200621762A (en) Novel compounds
CY1110979T1 (el) Παραγωγα κιναζολινης ως αναστολεις αγγειογενεσης και ενδιαμεσες ενωσεις αυτων
JP2014510774A5 (https=)
JOP20240217A1 (ar) مشتقات الكوينولين كمُعدِّلات للعضو x2 لمستقبل بروتين g مرتبط بـ mas ومنتجات ذات صلة
EA200501315A1 (ru) 8-ЗАМЕЩЁННЫЕ ПРОИЗВОДНЫЕ 6,7,8,9-ТЕТРАГИДРОПИРИМИДО[1,2-a]ПИРИМИДИН-4-ОНА
RU2009103300A (ru) Производные 2-бензоилимидазопиридинов, их получение и их применение в терапии
PH12020550761A1 (en) 6,7-DIHYDROPYRAZOLO[1,5-a]PYRAZINONE DERIVATIVE AND MEDICAL USE THEREOF
NZ761680A (en) Imidazo[1,5-a]pyrazine derivatives as pi3kdelta inhibitors
JP2016512818A (ja) テトランドリンファミリーの医薬製剤及び方法
JP2021523936A5 (https=)
JP2010535204A5 (https=)
TNSN02096A1 (en) Processes for the preparation of substituted bicyclic derivatives for the treatment of abnormal cell growth
HUP0303253A2 (hu) Aril-karbamát-származékok, eljárás előállításukra és alkalmazásuk
JOP20240119A1 (ar) مشتقات نافثيريدينون لمعالجة مرض أو اضطراب